Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Pharmacology & Therapeutics|December 12, 2018
HMGB1 and repair: focus on the heartLaura Pellegrini, Eleonora Foglio, Elena Pontemezzo, et al.
Biomedicines|August 29, 2024
Cardiomyocyte Regeneration in Human MyocarditisAndrea Frustaci, Eleonora Foglio, Federica Limana, et al.
Oxidative Medicine and Cellular Longevity|July 27, 2019
Hypoxia and Inflammation as a Consequence of <i>β</i>-Fibril Accumulation: A Perspective View for New Potential Therapeutic TargetsMatteo A Russo, Carlo Tomino, Enza Vernucci, et al.
International Journal of Molecular Sciences|November 21, 2020
PlGF Immunological Impact during PregnancyLoredana Albonici, Monica Benvenuto, Chiara Focaccetti, et al.
Oxidative Medicine and Cellular Longevity|January 23, 2016
The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and ProgressionMarco Tafani, Luigi Sansone, Federica Limana, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 2, 2002
bcl-2 overexpression promotes myocyte proliferationFederica Limana, Konrad Urbanek, Stefano Chimenti, et al.
Cancers|March 21, 2020
MicroRNAs in Cancer Treatment-Induced CardiotoxicityLaura Pellegrini, Sara Sileno, Marco D'Agostino, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 17, 2015
One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?Matteo A Russo, Luigi Sansone, Ilaria Carnevale, et al.
The EMBO Journal|December 31, 2002
Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulationAnnarosa Leri, Sonia Franco, Antonella Zacheo, et al.
Plos One|July 7, 2011
HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3Federica Limana, Grazia Esposito, Daniela D'Arcangelo, et al.
Pageof 4